Health Evidence HUB

Complications of Prostatitis and Evidence‑Based Natural Treatment Approaches

Published: June 2025· Language: EN ·

Institutions Referenced: Havard University and MDPI(Medical Sciences, Life & Uro)

Abstract

Prostatitis is an inflammatory condition of the prostate that can be acute or chronic and affects men across age groups. Typical symptoms include pelvic pain and lower urinary tract complaints. When diagnosis and treatment are delayed—especially in acute bacterial cases—serious complications such as prostatic abscess, urinary retention, progression to chronic disease, and sepsis may occur. For chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), multimodal care is recommended. Evidence suggests that, alongside conventional therapies, certain natural options (standardized pollen extract, Serenoa repens with lycopene and bromelain, and quercetin) can produce clinically meaningful improvements with good tolerability. Early evaluation and an individualized, supervised plan are essential.

Key Highlights

  • Delayed care—especially in acute bacterial prostatitis—can lead to abscess and sepsis.
  • CP/CPPS usually benefits from multimodal treatment rather than single‑drug approaches.
  • Standardized pollen extract has shown reductions in pain and urinary symptoms in clinical studies.
  • Combinations with *Serenoa repens*, lycopene, and bromelain improved NIH‑CPSI/IPSS scores in cohorts.
  • Quercetin (500 mg twice daily) improved symptoms in a randomized, placebo‑controlled trial.

1. Introduction

Prostatitis is an inflammation of the prostate that may present as acute bacterial infection or chronic forms, infectious or non‑infectious. Common symptoms include pelvic pain (perineal, suprapubic, testicular, or penile) and both irritative and obstructive urinary complaints, sometimes with painful ejaculation. These features can overlap with benign prostatic hyperplasia (BPH), complicating diagnosis (Dickson, 2013; Graziani et al., 2023).

2. Clinical presentation

Men typically report: (a) pelvic pain or pressure; (b) irritative symptoms—urinary frequency, urgency, nocturia; (c) obstructive symptoms—weak stream, hesitancy, post‑void dribbling, incomplete emptying; and (d) dysuria. In chronic cases, sexual dysfunction and painful ejaculation may occur, reducing quality of life (Graziani et al., 2023).

3. Potential complications if care is delayed

Delayed or inadequate treatment — particularly in acute bacterial prostatitis—can lead to prostatic abscess requiring drainage, acute urinary retention, evolution to chronic disease, systemic spread and sepsis, and fistulas or spread to adjacent structures (bladder, rectum) and, rarely, distant sites (spine, sacroiliac joints) (Dickson, 2013). Chronic inflammation has also been linked with reduced semen quality and male infertility in some patients (Graziani et al., 2023; Shiramizu et al., 2025).

4. Conventional management

Management depends on etiology. Acute and chronic bacterial forms require culture‑guided antibiotics for adequate duration. For non‑infectious CP/CPPS, clinicians may employ anti‑inflammatories, α‑blockers, pelvic‑floor physiotherapy, and behavioral measures. Because single‑modality regimens often provide incomplete relief, guidelines emphasize multimodal, personalized plans (Dashdondov et al., 2021; Dickson, 2013).

5. Evidence on natural/complementary options

Natural options should complement—not replace—medical supervision. Evidence highlights the following: • Standardized pollen extract: multicenter study in CP/CPPS showed greater reductions in pelvic pain and urinary scores versus α‑blocker alone, with good tolerability (Ivănuță et al., 2025). • *Serenoa repens* with lycopene and bromelain: 3‑month cohort reported improved NIH‑CPSI and IPSS with good safety (Saladino et al., 2023). • Quercetin: randomized trial demonstrated symptom benefits at 500 mg twice daily (Shoskes et al., 1999; NCBI, 2024).

6. Practical notes

Seek prompt evaluation for pelvic pain, burning urination, or fever at your local health facility. Complete antibiotic courses when prescribed. For chronic symptoms, discuss multimodal care and evidence‑based natural options with your clinician. Hydration, regular movement (break up long sitting), and limiting alcohol/caffeine/spicy foods may help.

7. Conclusion

Prostatitis is common and burdensome. Early diagnosis and appropriate therapy are crucial to prevent serious complications. For chronic cases, personalized multimodal care can improve outcomes. Certain natural options—standardized pollen extract, *Serenoa repens* with lycopene/bromelain, and quercetin—may provide additional relief when supervised by a clinician.

References

      1. Dashdondov, O., et al. (2021) ‘Herbal nutraceutical treatment of chronic prostatitis/chronic pelvic pain syndrome: a literature review’, International Urology and Nephrology, 53, pp. 1515–1528.
      2. Dickson, G. (2013) ‘Prostatitis—diagnosis and treatment’, Australian Family Physician, 42(4). Available at: https://www.racgp.org.au/afp/2013/april/prostatitis.
      3. Graziani, A., et al. (2023) ‘Chronic prostatitis/chronic pelvic pain syndrome and male infertility’, Life, 13(8), 1700. Available at: https://www.mdpi.com/2075-1729/13/8/1700.
      4. Ivănuță, M., et al. (2025) ‘Clinical evaluation of a pollen-extract-based phytotherapy compared to conventional therapies in CP/CPPS’, Medical Sciences, 13(3), 186. Available at: https://www.mdpi.com/2076-3271/13/3/186.
      5. NCBI (2024) Chronic Prostatitis and Chronic Pelvic Pain Syndrome in Men. Available at: https://www.ncbi.nlm.nih.gov/books/NBK599550/.
      6. Saladino, M., et al. (2023) ‘Efficacy and safety of a natural supplement containing Serenoa repens, lycopene, and bromelain in CP/CPPS: a prospective cohort study’, Uro, 3(3), pp. 199–207. Available at: https://www.mdpi.com/2673-4397/3/3/21.
      7. Shiramizu, S., et al. (2025) ‘An exceptionally rare case of acute prostatitis caused by Myroides odoratimimus infection’, Cureus, 17(7), e88554. Available at: https://pdfs.semanticscholar.org/4743/89febe172fd00f07ee2ccf21eb698e60fc62.pdf.
      8. Shoskes, D.A., et al. (1999) ‘Quercetin in men with category III chronic prostatitis: a prospective, randomized, double-blind, placebo-controlled trial’, Urology, 54(6), pp. 960–963. PubMed: https://pubmed.ncbi.nlm.nih.gov/10604689/.
  1. Dashdondov, O., et al. (2021) ‘Herbal nutraceutical treatment of chronic prostatitis/chronic pelvic pain syndrome: a literature review’, International Urology and Nephrology, 53, pp. 1515–1528.
  2. Dickson, G. (2013) ‘Prostatitis—diagnosis and treatment’, Australian Family Physician, 42(4). Available at: https://www.racgp.org.au/afp/2013/april/prostatitis.
  3. Graziani, A., et al. (2023) ‘Chronic prostatitis/chronic pelvic pain syndrome and male infertility’, Life, 13(8), 1700. Available at: https://www.mdpi.com/2075-1729/13/8/1700.
  4. Ivănuță, M., et al. (2025) ‘Clinical evaluation of a pollen-extract-based phytotherapy compared to conventional therapies in CP/CPPS’, Medical Sciences, 13(3), 186. Available at: https://www.mdpi.com/2076-3271/13/3/186.
  5. NCBI (2024) Chronic Prostatitis and Chronic Pelvic Pain Syndrome in Men. Available at: https://www.ncbi.nlm.nih.gov/books/NBK599550/.
  6. Saladino, M., et al. (2023) ‘Efficacy and safety of a natural supplement containing Serenoa repens, lycopene, and bromelain in CP/CPPS: a prospective cohort study’, Uro, 3(3), pp. 199–207. Available at: https://www.mdpi.com/2673-4397/3/3/21.
  7. Shiramizu, S., et al. (2025) ‘An exceptionally rare case of acute prostatitis caused by Myroides odoratimimus infection’, Cureus, 17(7), e88554. Available at: https://pdfs.semanticscholar.org/4743/89febe172fd00f07ee2ccf21eb698e60fc62.pdf.
  8. Shoskes, D.A., et al. (1999) ‘Quercetin in men with category III chronic prostatitis: a prospective, randomized, double-blind, placebo-controlled trial’, Urology, 54(6), pp. 960–963. PubMed: https://pubmed.ncbi.nlm.nih.gov/10604689/.
Back to Prostalix Home

This article is provided for educational purposes and should not substitute professional medical advice. If you have symptoms, consult a qualified clinician.